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It is known that glycolysis contributes to the survival of tumor cells by providing them with energetic and plastic substrates. Dichloro-
acetate (DCA) as inhibitor of kinase pyruvate dehydrogenase shifts balance of energy metabolism of tumor cells from aerobic glycoly-
sis towards oxidative phosphorylation. The aim of the study was to investigate cytostatic/cytotoxic effect of DCA on glioma C6 cells 
at the conditions of different oxygenation of the cell incubation medium. Materials and Methods: DCA action on glioma C6 cells was 
investigated upon the conditions of normoxia, hypoxia (1% of oxygen) and hyperoxia (30% and 95% of oxygen) in vitro. The number 
and viability of tumor cells were assessed using trypan blue dye-exclusion test. Apoptosis was determined using dye Hoechst 33258. 
Lactate production by tumor cells was determined by enzymatic method using lactate dehydrogenase. Cell cycle distribution was 
studied using flow cytometry. Reactive oxygen species (ROS) content was evaluated using 2´,7´-dichlorofluorescein diacetate. Results: 
By the data of in vitro cytotoxicity, upon hypoxia IC50 value of DCA was three times lower (p < 0.05) than that upon normoxic condi-
tions (18.2 ± 3.9 mM vs. 51.2 ± 8.1 mM). Hypoxia itself enhanced the ROS production in glioma cells by 113.5% (p < 0.05) that 
correlated with increase of apoptosis by 292% (p < 0.05). In hypoxic glioma C6 cells DCA did not significantly influence the ROS 
production, but decreased hypoxia-induced apoptosis by 3.5–6.5 times (p < 0.05) and significantly increased cell death rates via 
necrosis (p < 0.05). In contrast to hypoxia, upon the conditions of hyperoxia IC50 values for DCA did not differ from the corre sponding 
values upon the normoxia conditions and at 30% and 95%oxygen content were equal to 35.8 ± 7.2 mM and 42.3 ± 5.1 mM respec-
tively. Conclusion: According to the obtained results, hypoxia enhances cytostatic/cytotoxic effects of DCA in glioma C6 cells via high 
level of DCA-induced necrosis of tumor cells and hypoxia-induced ROS hyperproduction.
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It is known that in most of malignant tumors, ATP 
is produced by means of glycolysis even in the pre-
sence of oxygen (Warburg effect). Despite aerobic 
glycolysis is less effective way of ATP generation 
compared with oxidative phosphorylation, it provides 
high proliferative potential of tumor cells and contri-
butes to their survival decreasing risks of the formation 
of apoptotic stimuli [1–3]. Therefore, in recent times, 
tumor metabolism, which provides tumor cells with 
such growth advantages, is actively considered as new 
target for the antitumor therapy, and compounds able 
to inhibit glycolysis in malignant cells are considered 
to have potential of effective antitumor drugs. Such 
anti-metabolic agent, which has showed antitumor ac-
tivity in the respect of many types of cancer cells [4–7], 
proved to be dichloroacetate (DCA), inhibitor of py-
ruvate dehydrogenase kinase (PDK) [8]. Capability 
of DCA to inhibit PDK is considered to underlie its an-
titumor activity. PDK is negative regulator of enzymes 
of mitochondrial pyruvate dehydrogenase (PDH) com-
plex, which plays key role in regulation of tricarbonic 
acid cycle and oxidative phosphorylation. In case of in-
activation (phosphorylation) of PDH complex by PDK, 
energy metabolism of tumor cell switches to glycolysis, 
but in catalytically active (non-phosphorylated) state, 
PDH complex regulates entrance of pyruvate in mito-
chondria and catalyzes its transformation in acetyl-
CoA — substrate for the tricarbonic acid cycle. DCA, 
by inhibiting activity of PDK, is able to stimulate indirect 
activation of enzymes of PDH complex and, therefore, 
cause shift of the energy balance of cell from glycolysis 
towards activation of oxidative phosphorylation.
In case of activation of oxidative phosphorylation 
and decrease of intensity of glycolysis caused by ac-
tion of DCA, the inhibition of tumor cell proliferation, 
in particular due to the significant decrease of hexose 
monophosphate shunt metabolites and pyruvate, 
which are critical for the synthesis of proteins and 
nucleic acids, may be expected. DCA-induced activa-
tion of mitochondrial metabolism can cause not only 
blocking of tumor cell proliferation, but also evoke 
intensification of mitochondrial-derived reactive oxy-
gen species (ROS) generation and induce apoptosis. 
However, despite theoretical clearness of antitumor 
effect of DCA, its efficacy is not guaranteed. Activation 
of oxidative phosphorylation evoked by action of DCA 
can cause not only antitumor effect, but also can con-
tribute to the survival of tumor cells, in particular due 
to the increase of ATP synthesis. For instance, in some 
studies, significant proapoptotic effect of DCA on tumor 
cells was determined [4–7], while in the other studies 
actually antiapoptotic effect of DCA was registered [9].
Nevertheless, taking into account the fact that DCA 
switches energy metabolism of tumor cell to the mainly 
oxidative phosphorylation, it should be expected that 
hypoxia, by limiting the activity of cellular respiration, 
can essentially amplify its antitumor effect. Therefore, 
the aim of this study was to investigate cytostatic/
cytotoxic effect of DCA on glioma C6 cells at different 
content of oxygen in the incubation medium.
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MATERIALS AND METHODS
Studies have been carried out using glioma C6 cells 
taken from National Bank of Cell Lines and Tumor 
Strains of IEPOR of NAS of Ukraine. Glioma cells were 
maintained in vitro in nutrient medium DMEM ad-
ding 10% ETC (Sigma, USA), 2 mM L-glutamine and 
40 mkg/ml of gentamicin at 37 °С in the humidified 
environment, 5% СО2.
Cytostatic/cytotoxic effect of DCA on glioma 
C6 cells was evaluated upon the conditions of incuba-
tion of cells in normoxia (21% O2), hypoxia (1% O2), 
and hyperoxia (30% and 95% O2). Various content 
of oxygen in incubation chamber was generated by ad-
justing of partial oxygen pressure using gases nitrogen 
and oxygen in corresponding ratios. Level of oxygen 
in incubation chamber was controlled using oximeter 
ISO2 (World precision instruments, USA).
The number of tumor cells and their viability were 
assessed by the dye-exclusion method using 0.4% 
trypan blue.
Glioma cells were seeded in 24-well plates at a den-
sity of 1,5•105 cells/well or in 6-cm dish at a density 
of 0,6•106 cells/dish and incubated under standard 
conditions overnight. After preincubation medium 
was replaced with fresh growth medium with DCA and 
after 24 h incubation upon corresponding conditions 
needed assays were performed.
Cell cycle distribution was examined by staining 
cells with propidium iodide using flow cytometry ac-
cording [10].
The apoptosis was evaluated using dye Hoechst 
33258 (Sigma, USA). For this, cells were stained 
by Hoechst 33258 in the final concentration 
1 μg/ml at 37 °С during 20 min and were washed out 
by salt solution. After that, changes of morphology of nu-
clei were assessed by counting not less than 500 cells/
sample. Apoptotic cells were determined by presence 
of fragmented nucleus or condensed chromatin and were 
expressed as a percentage from the total number of cells.
ROS production in tumor cells was assayed using 
2,7-dichlorfluorescein-diacetate (Sigma, USA) [11]. 
The fluorescence was monitored by a fluorophoto-
meter. The excitation wavelength was set at 485 nm, 
while the emission wavelength was 520 nm.
To assess the effect of DCA on tumor cell lactate 
production the supernatants were analyzed for lac-
tate concentration using enzymatic spectrophoto-
metric method with lactate dehydrogenase (Sigma, 
USA) [12]. Lactate production rates were expressed 
relative to the number of viable cells.
Statistical analysis of the obtained data was carried 
out using descriptive methods, t-test, and nonlinear 
regression analysis.
RESULTS AND DISSCUSSION
Study of impact of DCA on glioma C6 cells was 
carried out at different content of oxygen in incuba-
tion medium: normoxia (21% of oxygen), hypoxia (1% 
of oxygen) and hyperoxia (30% and 95% of oxygen). 
According to the obtained data, not only DCA, but also 
hypoxia actually shows cytostatic/cytotoxic effect. 
For instance, hypoxia alone significantly decreased 
proliferation of glioma C6 cells that was evident by sig-
nificant 48% decrease (p < 0.05) of the number of the 
viable cells upon the conditions of hypoxia compared 
with the same upon the conditions of normoxia. De-
crease of the number of viable cells upon the condi-
tions of hypoxia took place, in particular, both due 
to the induction of apoptosis and tumor cell blocking 
in G0/G1. For instance, hypoxia caused the 23% 
increase of cells in phases G0/G1 (p < 0.05) and 
significant decrease (almost in half, p < 0.05) of their 
quantity in the S-phase. Significant increase of level 
of apoptosis observed upon the conditions of hy-
poxia correlated with significant increase of generation 
of ROS by tumor cells. The number of apoptotic cells 
upon the conditions of hypoxia increased on 292% 
(p < 0.05), and level of generation of ROS increased 
on 113.5% (p < 0.05) compared with the corresponding 
indices upon the conditions of normoxia. No significant 
increase of number of necrotic cells upon the condi-
tions of hypoxia was observed. It should be mentioned 
that expected increase of activity of glycolysis in glioma 
cells caused by hypoxia is confirmed by statistically 
significant increase of lactate production rate by glio-
ma cells on 207% (p < 0.05).
Thus, strong decrease of tumor cell proliferation, 
high level of generation of ROS and, therefore, high level 
of hypoxia-induced apoptosis were the evidence of high 
sensitivity of glioma C6 cells to hypoxia. Hy peroxia (30% 
and 95% of oxygen), in the contrast to hypoxia, did not 
essentially influence the studied indices.
Data on the impact of DCA on glioma C6 cells 
showed that its cytostatic/cytotoxic effect was sig-
nificantly enhanced upon the conditions of hypoxia. 
For instance, concentration of compound, which 
caused up to the 50% decrease of the number of vi-
able cells due to its cytostatic and/or cytotoxic action 
(IC50), was almost threefold lower upon the conditions 
of hypoxia compared with the same upon the condi-
tions of normoxia and equaled 18.2 ± 3.9 mM and 
51.2 ± 8.1 mM respectively (Fig. 1).
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Fig. 1. The action of DCA on glioma C6 cell viability upon 
the conditions of hypoxia
The fact attracts attention that upon the conditions 
of normoxia, DCA decreases the number of viable cells 
mainly due to the realization of its cytostatic effect. 
As seen in Fig. 2, the number of necrotic cells was 
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not changed significantly and did not exceed 10% 
from the total number of tumor cells even at maximal 
concentrations of the compound. Predominance 
of cytostatic effect of DCA on glioma cells upon 
the conditions of normoxia is confirmed also by its low 
proapoptotic activity. According to the literature data, 
one of the mechanisms of antitumor effect of DCA is its 
capability to enhance ROS production and, therefore, 
to induce apoptosis [4–7].
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Fig. 2. DCA-induced necrosis in glioma C6 cells upon the condi-
tions of hypoxia
DCA-induced apoptosis was observed in many 
types of tumor cells, in particular colorectal cancer [7], 
human glioblastoma cells in vitro and in vivo [6], endo-
metrial cancer cells [5], etc. Meanwhile, in this study, 
DCA has not significantly influence the level of apop-
tosis upon the conditions of normoxia. The number 
of apoptotic glioma cells after their incubation with 
DCA in the wide range of concentrations, did not sta-
tistically differ from that in control (Table 1).
Table 1. Effect of DCA on apoptosis in glioma C6 cells upon the condi-
tions of hypoxia
DCA, mM Normoxia, % Hypoxia, %
0 3.8 ± 1.7 14.9 ± 0.05*
7.5 3.2 ± 0.2 2.3 ± 0.08*,#
15 3.4 ± 0.2 4.2 ± 0.72
30 4.5 ± 0.4 4.3 ± 0.72
60 14.1 ± 2.8 3.5 ± 0.32
Note: *p < 0.05 vs. corresponding index upon the conditions of normo-
xia; #p < 0.05 vs. corresponding index upon the conditions of hypoxia itself.
In contrast to normoxia, it was determined that 
DCA upon the conditions of hypoxia showed mainly 
significant cytotoxic effect (see Fig. 2). In particu-
lar, DCA in concentration 15 mM caused more than 
fivefold increase of number of dead cells compared 
with the same upon the conditions of normoxia 
(12.6 ± 3.4% against 2.3 ± 0.3%, p < 0.05). In concen-
tration of DCA 60 mM, number of dead cells increased 
up to 60.4 ± 4.2%, which was tenfold higher than cor-
responding index upon the conditions of normoxia.
On the background of enhancement of ne-
crotic death of cells as a result of DCA action upon 
the conditions of hypoxia, significant decrease of the 
level of hypoxia-induced apoptosis was registered 
(Table 1). As it was previously showed, hypoxia 
caused the fourfold (p < 0.05) increase of the number 
of apoptotic cells compared with the corresponding 
index upon the conditions of normoxia. Upon hypoxic 
conditions, DCA regardless of its concentration fully 
inhibited hypoxia-induced apoptosis causing the de-
crease of the number of apoptotic cells 3.5–6.5 times 
(p < 0.05) compared with the corresponding index 
upon the hypoxic conditions itself. It was shown that 
DCA decreased apoptosis in some cell lines of human 
colorectal cancer upon the conditions of hypoxia that 
is considered by authors to be connected with HIF-1a-
dependent signal cascades [9].
In contrast to hypoxia, hyperoxia did not significantly 
enhance cytostatic/cytotoxic effect of DCA on C6 cells. 
The calculated IC50 both upon the conditions of 30% 
and 95% of the content of О2 in the incubation medium 
did not significantly differ from the corresponding index 
upon the conditions of normoxia (35.8 ± 7.2 mM and 
42.3 ± 5.1 mM correspondingly against 51.2 ± 8.1 mM) 
(Fig. 3). If upon the conditions of hypoxia decrease 
of the number of viable cells was caused mainly 
by the cytotoxic effect of DCA, then upon the condi-
tions of hyperoxia — due to the realization of the mainly 
cytostatic effect of DCA (Fig. 4). For instance, number 
of dead cells even at extremely high concentrations 
of DCA (120 mM) upon the conditions of 30% oxygen 
content in the incubation medium did not markedly dif-
fer from the corresponding index upon the conditions 
of normoxia. Only upon the conditions of 95% oxygen 
content DCA in the same high concentration signifi-
cantly (p < 0.05) increased cell death up to 30 ± 0.1%. 
DCA did not increase apoptosis in glioma cells upon 
the conditions of hyperoxia (Table 2).
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Fig. 3. The action of DCA on glioma C6 cell viability upon the con-
ditions of hyperoxia
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Fig. 4. DCA-induced necrosis in glioma C6 cells upon the condi-
tions of hyperoxia
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Table 2. Effect of DCA on apoptosis in glioma C6 cells upon the condi-
tions of hyperoxia
DCA, mM Normoxia Hyperoxia (30%)
0 2.3 ± 0.3 3.0 ± 1.1
7.5 2.3 ± 0.2 3.0 ± 0.3
15 2.0 ± 0.2 2.9 ± 0.01
30 6.8 ± 3.8 4.8 ± 1.5
60 5.0 ± 1.3 5.7 ± 1.7
It was shown that DCA did not cause significant 
action on the cell cycle (Tables 3, 4). According 
to the obtained data, upon the conditions of normoxia 
only treatment of tumor cells with DCA in concentra-
tions higher than IC50 resulted in statistically significant 
increase (p < 0.05) of cells in phase G0/G1 and de-
crease (p < 0.05) of cells in S-phase. Lack of capability 
of DCA to redistribute tumor cells by phases of cell 
cycle is the evidence that its cytostatic action, appa-
rently, was conditioned by its ability to block their cell 
cycle progression into the all phases.
Table 3. Effects of DCA on the cell cycle of glioma C6 cells upon the con-
ditions of hypoxia
DCA, 
mM
Normoxia Hypoxia
G0/G1 G2/M S G0/G1 G2/M S
0 56.9 ± 0.3 16.6 ± 0.6 26.5 ± 0.3 70.2 ± 0.9* 15.8 ± 0.6 14.0 ± 0.2*
7.5 55.2 ± 0.7 14.9 ± 0.6 29.9 ± 0.1 71.2 ± 1.1 15.2 ± 0.3 13.6 ± 1.4
15 54.5 ± 1.0 17.5 ± 0.2 28.0 ± 0.8 67.2 ± 1.5 16.4 ± 0.5 16.4 ± 0.6
30 57.3 ± 1.1 20.1 ± 0.7 22.7 ± 0.4 68.0 ± 0.7 19.4 ± 0.8 12.7 ± 0.3
60 63.8 ± 1.3* 18.1 ± 0.4 18.1 ± 0.8* 66.6 ± 0.7 22.3 ± 1.4 11.1 ± 0.7
Note: *p < 0.05 vs. corresponding index upon the conditions of normoxia.
Table 4. Effects of DCA on the cell cycle of glioma C6 cells upon the con-
ditions of hyperoxia
DCA, 
mM
Normoxia Hyperoxia (30%)
G0/G1 G2/M S G0/G1 G2/M S
0 51.2 ± 1.6 18.7 ± 1.1 30.1 ± 0.5 47.8 ± 0.3* 22.3 ± 0.5 29.9 ± 0.9
7.5 51.2 ± 1.0 20.8 ± 0.2 28.0 ± 0.8 46.7 ± 0.7 23.1 ± 0.1 30.2 ± 0.8
15 50.6 ± 0.5 21.0 ± 0.2 28.3 ± 0.7 46.4 ± 1.2 21.7 ± 1.2 31.9 ± 0.0
30 48.7 ± 0.5 22.3 ± 0.6 29.0 ± 0.1 45.8 ± 0.1 23.0 ± 1.0 31.2 ± 1.1
60 54.8 ± 1.5 19.5 ± 1.2 25.7 ± 1.1 50.5 ± 1.7 18.0 ± 1.5 31.5 ± 0.9
Note: *p < 0.05 vs. corresponding index upon the conditions of normoxia.
Data concerning with DCA action on the ROS 
production by tumor cells as one of the possible 
ways of realization of its cytostatic/cytotoxic effect 
are represented in Fig. 5. In this study, statistically 
significant increase of intracellular ROS level in glioma 
C6 cells as a result of DCA treatment was observed 
only upon the conditions of extreme hyperoxia. In par-
ticular, as seen in Fig. 5, upon the conditions of 95% 
hy peroxia, DCA in concentration of 30 mM caused 
up to 66% (p < 0.01) of increase of ROS production 
by tumor cells. Upon the conditions of normoxia, DCA 
in the range of concentrations 20–60 mM, i.e., in con-
centrations lower and closer to IC50, did not cause 
significant increase of ROS production instead. DCA 
ability to increase of ROS level on 85–91% in glioma 
cells upon the normoxia conditions was observed only 
in extremely high concentrations (120–240 mM), which 
significantly exceed IC50 (data are not presented).
Lactate production rate was assessed as surro-
gate marker of DCA inhibition of glycolysis. Obtained 
results are represented in Table 5. According to the ob-
tained data, only upon the conditions of hypoxia, DCA 
in the range of concentrations close to IC50 slightly 
slowed down lactate production by glioma cells. 
At least, DCA treatment in concentration of 15 mM 
(which was almost equal to its IC50 upon the conditions 
of hypoxia) and 60 mM caused 21% and 32% decrease 
(p < 0.05) of lactate production rate by glioma cells 
compared with the same in the conditions of hypoxia it-
self. At the same time, upon the conditions of normoxia 
and hyperoxia, no essential impact of DCA on lactate 
production rate was detected.
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Fig. 5. Effect of DCA on ROS production by glioma cells.
Note: *p < 0.05 vs. corresponding index upon the conditions of normoxia; 
p < 0.05 vs. corresponding index upon the conditions of hyperoxia itself.
Table 5. Effect of DCA on lactate production rate by glioma cells under 
different oxygen contents
DCA, mM Lactate production rate (mkmol/10
6 cells per hour)
Normoxia Hypoxia (1% О2) Hyperoxia (95% О2)
0 0.45 ± 0.03 1.38 ± 0.06 0.63 ± 0.15
15 0.48 ± 0.04 1.09 ± 0.11 0.44 ± 0.18
30 0.49 ± 0.09 1.18 ± 0.43 0.62 ± 0.04
60 0.52 ± 0.07 0.94 ± 0.08* 0.89 ± 0.18
Note: *p < 0.05 vs. corresponding index upon the conditions of hypoxia itself.
Thus, in this study, no apparent ability of DCA to in-
crease ROS production by glioma C6 cells and induce 
apoptosis upon the conditions of hypoxia, as well 
as normoxia and hyperoxia was detected. Obviously, 
cytostatic/cytotoxic activity of DCA on glioma C6 cells 
realizes not due to the hyperproduction of ROS and ini-
tiation of apoptosis, but rather due to its ability to mo-
dify energy metabolism in tumor cells. It is confirmed 
by data on the action of DCA upon hypoxia, to be exact, 
high level of necrotic death of tumor cells. By amplify-
ing activity of PDH complex and, therefore, rendering 
impossible compensatory activation of glycolysis 
in tumor cells, DCA, appa rently, essentially li mited 
their metabolic adaptation to hypoxia that caused 
fast decrease of ATP and emergence of metabolic 
catastrophe. Meanwhile, it is known that both rapid 
decrease of ATP in tumor cell due to the inhibition 
of energy metabolism and activation of proapoptotic 
signals upon the conditions of significant limitation 
of the level of intracellular ATP induce necrosis [13, 
14]. Ability of DCA to cause dramatic decrease of in-
tracellular ATP has been showed, at least for cervical 
carcinoma cells [15].
Impact of DCA on the energy metabolism of glioma 
C6 cells is confirmed not only by increase of level 
of their necrotic death, but also decrease of lactate 
production rate. Upon the conditions of hypoxia, DCA 
caused 21–32% decrease of the lactate production 
by glioma cells that was the evidence of DCA-induced 
inhibition of glycolysis on the background of the ex-
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pected decrease of glutaminolysis. Concerning 
normoxia conditions, lack of inhibiting impact of DCA 
on lactate production by glioma C6 cells can be ex-
plained by compensatory activation of glutaminolysis 
(as the main supplier of ATP in the most of tumor cells 
cultured in vitro) as a result of activation of oxidative 
phosphorylation.
Thus, it has been established that hypoxia sig-
nificantly increases cytostatic/cytotoxic action of DCA 
on glioma C6 cells — tumor cells, which turned 
out to be sensitive to hypoxia alone. Obtained data 
on hypoxia-induced hyperproduction of ROS in tumor 
cells, as well as high level of DCA-induced necrotic 
death of these cells, show that enhancement of its 
cytostatic/cytotoxic effect on glioma C6 cells upon 
the conditions of hypoxia was connected both with 
its impact on the tumor metabolism and high level 
of hypoxia-induced ROS.
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